Am. J. Respir. Cell Mol. Biol., Volume 19, Number 4, October, 1998 606-612

Proliferation of Human Non-Small-Cell Lung Cancer Cell Lines: Role of Interleukin-6

Michel Bihl, Michael Tamm, Markus Nauck, Heinrich Wieland, André P. Perruchoud, and Michael Roth

Division of Pneumology, Department of Internal Medicine and Research, University Hospital, Basel, Switzerland; and Department of Clinical Chemistry, University Hospital, Freiburg, Germany

Interleukin-6 (IL-6) is involved in regulation of the immune response, acute phase reaction, and cell proliferation. The aim of this study was to investigate whether IL-6 is implicated in cell proliferation of human non-small-cell lung cancer (NSCLC) cell lines. We analyzed IL-6 messenger RNA (mRNA) and protein expression in eight NSCLC cell lines: A549, Calu3, Calu6, H23, H522, H810, H1155, and H1299. The A549, Calu3, Calu6, and H23 cell lines expressed IL-6 mRNA and protein. In these cell lines, fetal calf serum (FCS) significantly increased cell proliferation as assessed by thymidine incorporation. In the presence of IL-6 antisense oligonucleotides, both proliferation and IL-6 synthesis were downregulated. In contrast, IL-6 mRNA and protein could not be detected in the NSCLC cell lines H522, H810, H1155, and H1299. In these NSCLC cell lines, FCS only marginally increased cell proliferation and IL-6 antisense oligonucleotides did not affect cell proliferation. The addition of neither exogenous IL-6 nor neutralizing anti-IL-6 antibodies affected cell proliferation in any of the experiments. Our data thus provide evidence that intracellular IL-6 is required in the control of cell proliferation in a subset of human NSCLC cell lines. We suggest the existence of two subtypes of NSCLC, an IL-6-dependent and an IL-6-independent type.

This article has been cited by other articles:

				S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells J. Biol. Chem., February 2, 2007; 282(5): 3014 - 3026. [Abstract] [Full Text] [PDF]

				C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, R. Zeillinger, G. Sliutz, A. Reinthaller, and L. A. Hefler A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer Reproductive Sciences, December 1, 2005; 12(8): 617 - 620. [Abstract] [PDF]

				H. Dalwadi, K. Krysan, N. Heuze-Vourc'h, M. Dohadwala, D. Elashoff, S. Sharma, N. Cacalano, A. Lichtenstein, and S. Dubinett Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non-Small Cell Lung Cancer Clin. Cancer Res., November 1, 2005; 11(21): 7674 - 7682. [Abstract] [Full Text] [PDF]

				K.-T. Chang, C.-Y. F. Huang, C.-M. Tsai, C.-H. Chiu, and Y.-Y. Lok Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L438 - L445. [Abstract] [Full Text] [PDF]

				K.-T. Chang, C.-M. Tsai, Y.-C. Chiou, C.-H. Chiu, K.-S. Jeng, and C.-Y. F. Huang IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L446 - L453. [Abstract] [Full Text] [PDF]

				Z. Zheng, G. Bepler, A. Cantor, and E. B. Haura Small Tumor Size and Limited Smoking History Predicts Activated Epidermal Growth Factor Receptor in Early-Stage Non-small Cell Lung Cancer Chest, July 1, 2005; 128(1): 308 - 316. [Abstract] [Full Text] [PDF]

				Y. To, M. Dohi, K. Matsumoto, R. Tanaka, A. Sato, K. Nakagome, T. Nakamura, and K. Yamamoto A Two-way Interaction between Hepatocyte Growth Factor and Interleukin-6 in Tissue Invasion of Lung Cancer Cell Line Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 220 - 226. [Abstract] [Full Text] [PDF]

				M. P. Bihl, K. Heinimann, J. J. Rudiger, O. Eickelberg, A. P. Perruchoud, M. Tamm, and M. Roth Identification of a Novel IL-6 Isoform Binding to the Endogenous IL-6 Receptor Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 48 - 56. [Abstract] [Full Text] [PDF]

				T. Yamaguchi, H. Kimura, S. Yokota, Y. Yamamoto, T. Hashimoto, M. Nakagawa, M. Ito, and T. Ogura Effect of IL-6 Elevation in Malignant Pleural Effusion on Hyperfibrinogenemia in Lung Cancer Patients Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 53 - 58. [Abstract] [Full Text] [PDF]

				O. Eickelberg, A. Pansky, R. Mussmann, M. Bihl, M. Tamm, P. Hildebrand, A. P. Perruchoud, and M. Roth Transforming Growth Factor-beta 1 Induces Interleukin-6 Expression via Activating Protein-1 Consisting of JunD Homodimers in Primary Human Lung Fibroblasts J. Biol. Chem., April 30, 1999; 274(18): 12933 - 12938. [Abstract] [Full Text] [PDF]